2015 Q2 Form 10-Q Financial Statement

#000101008615000008 Filed on May 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $1.500M $1.200M $500.0K
YoY Change 114.29% 140.0% -61.54%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.605M $3.088M $3.039M
YoY Change -5.2% 1.61% 1.84%
% of Gross Profit
Research & Development $2.959M $2.811M $2.813M
YoY Change 24.75% -0.07% -22.83%
% of Gross Profit
Depreciation & Amortization $68.08K $78.78K $91.11K
YoY Change -24.1% -13.53% -7.16%
% of Gross Profit
Operating Expenses $5.800M $6.232M $6.188M
YoY Change 7.47% 0.71% -13.27%
Operating Profit -$4.332M -$5.040M -$5.638M
YoY Change -8.74% -10.61% -2.91%
Interest Expense $13.32K $253.4K $140.8K
YoY Change -89.23% 79.94% -62.3%
% of Operating Profit
Other Income/Expense, Net $10.88K $5.464K $5.00
YoY Change 934.92% 109180.0% -95.15%
Pretax Income $6.500M $7.100M -$5.623M
YoY Change -237.62% -226.26% -21.4%
Income Tax $88.35K $83.83K -$2.241M
% Of Pretax Income 1.36% 1.18%
Net Earnings -$6.573M -$7.153M -$3.382M
YoY Change 122.96% 111.5% -30.64%
Net Earnings / Revenue -438.2% -596.08% -676.4%
Basic Earnings Per Share
Diluted Earnings Per Share -$123.1K -$134.6K -$63.79K
COMMON SHARES
Basic Shares Outstanding 53.50M shares 53.50M shares 53.26M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $115.7M $95.50M $107.1M
YoY Change 16.87% -10.83% 333.6%
Cash & Equivalents $115.7M $95.55M $107.1M
Short-Term Investments
Other Short-Term Assets $8.000M $6.700M $8.600M
YoY Change -39.39% -22.09% -75.07%
Inventory $8.770M $14.82M $17.08M
Prepaid Expenses
Receivables $769.2K $14.27M $610.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $133.2M $131.3M $133.3M
YoY Change 2.65% -1.52% 28.79%
LONG-TERM ASSETS
Property, Plant & Equipment $446.6K $753.2K $1.085M
YoY Change -55.37% -30.56% -6.36%
Goodwill $898.3K $898.3K $898.3K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.990M $1.990M $2.025M
YoY Change -0.5% -1.73% -4.72%
Total Long-Term Assets $49.29M $41.93M $81.45M
YoY Change -38.18% -48.52% 223.28%
TOTAL ASSETS
Total Short-Term Assets $133.2M $131.3M $133.3M
Total Long-Term Assets $49.29M $41.93M $81.45M
Total Assets $182.5M $173.2M $214.8M
YoY Change -12.89% -19.34% 66.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.781M $3.553M $4.344M
YoY Change 193.61% -18.2% -49.43%
Accrued Expenses $3.243M $3.424M $4.661M
YoY Change -32.12% -26.54% 2.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.974M
YoY Change -100.0% -100.0% 35.74%
Total Short-Term Liabilities $8.024M $6.977M $11.14M
YoY Change -4.44% -37.35% -26.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $1.494M
YoY Change -100.0% -100.0% -56.91%
Other Long-Term Liabilities $426.8M $413.0M $188.2M
YoY Change 126.42% 119.45% 122.46%
Total Long-Term Liabilities $426.8M $413.0M $1.494M
YoY Change 42678.69% 27534.85% -56.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.024M $6.977M $11.14M
Total Long-Term Liabilities $426.8M $413.0M $1.494M
Total Liabilities $441.9M $426.4M $200.9M
YoY Change 123.27% 112.32% 94.57%
SHAREHOLDERS EQUITY
Retained Earnings -$435.7M -$429.1M -$159.9M
YoY Change 167.54% 168.37% 10.87%
Common Stock $176.3M $175.9M $173.8M
YoY Change 1.09% 1.21% 2.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$259.4M -$253.2M $13.94M
YoY Change
Total Liabilities & Shareholders Equity $182.5M $173.2M $214.8M
YoY Change -12.89% -19.34% 66.86%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$6.573M -$7.153M -$3.382M
YoY Change 122.96% 111.5% -30.64%
Depreciation, Depletion And Amortization $68.08K $78.78K $91.11K
YoY Change -24.1% -13.53% -7.16%
Cash From Operating Activities $20.10M -$6.168M $16.59M
YoY Change -349.07% -137.17% -305.01%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $14.18K
YoY Change -100.0% -100.0% -94.72%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$4.000M $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $4.000M -$14.18K
YoY Change -100.0% -28300.79% -94.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $2.000M $500.0K
YoY Change 300.0%
Cash From Financing Activities 10.00K -$2.000M -$821.3K
YoY Change -102.04% 143.53% -179.33%
NET CHANGE
Cash From Operating Activities 20.10M -$6.168M $16.59M
Cash From Investing Activities 0.000 $4.000M -$14.18K
Cash From Financing Activities 10.00K -$2.000M -$821.3K
Net Change In Cash 20.11M -$4.168M $15.76M
YoY Change -350.12% -126.45% -315.06%
FREE CASH FLOW
Cash From Operating Activities $20.10M -$6.168M $16.59M
Capital Expenditures $0.00 $0.00 $14.18K
Free Cash Flow $20.10M -$6.168M $16.58M
YoY Change -349.69% -137.21% -298.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-184027 USD
CY2015Q1 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
0 USD
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001010086
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53504296 shares
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
SIGA TECHNOLOGIES INC
CY2015Q1 dei Trading Symbol
TradingSymbol
SIGAQ
CY2015Q1 siga Bankruptcy Claimsamountofliquidatedclaims
BankruptcyClaimsamountofliquidatedclaims
202962049 USD
CY2015Q1 siga Bankruptcyclaimsamountofunliquidatedclaim
Bankruptcyclaimsamountofunliquidatedclaim
109339609 USD
CY2014Q1 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-156105 USD
CY2014Q2 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-129398 USD
CY2014Q3 siga Collateral
Collateral
0.50
CY2014Q4 siga Computer Equipment
ComputerEquipment
669782 USD
CY2015Q1 siga Computer Equipment
ComputerEquipment
669782 USD
CY2015Q1 siga Courses Delivered Provisional Dosage Twice Daily
CoursesDeliveredProvisionalDosageTwiceDaily
100000 course
CY2015Q1 siga Debt Satisfied
DebtSatisfied
1800000 USD
CY2014Q1 siga Expenseof Warrants Heldas Assets
ExpenseofWarrantsHeldasAssets
34091 USD
CY2015Q1 siga Expenseof Warrants Heldas Assets
ExpenseofWarrantsHeldasAssets
34091 USD
CY2015Q1 siga Finalorderandjudgmentplusinterest
Finalorderandjudgmentplusinterest
195000000 USD
CY2014Q1 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
-156105 USD
CY2015Q1 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
0 USD
CY2014Q1 siga Inventory Write Downs
InventoryWriteDowns
500000 USD
CY2015Q1 siga Inventory Write Downs
InventoryWriteDowns
27000 USD
CY2014Q4 siga Liabilitiessubjecttocompromiseaccountspayable
Liabilitiessubjecttocompromiseaccountspayable
3502607 USD
CY2015Q1 siga Liabilitiessubjecttocompromiseaccountspayable
Liabilitiessubjecttocompromiseaccountspayable
3568874 USD
CY2014Q4 siga Liabilitiessubjecttocompromisedeferredrevenue
Liabilitiessubjecttocompromisedeferredrevenue
203696194 USD
CY2015Q1 siga Liabilitiessubjecttocompromisedeferredrevenue
Liabilitiessubjecttocompromisedeferredrevenue
203652182 USD
CY2014Q4 siga Liabilitiessubjecttocompromiselosscontingencylegalfees
Liabilitiessubjecttocompromiselosscontingencylegalfees
3226055 USD
CY2015Q1 siga Liabilitiessubjecttocompromiselosscontingencylegalfees
Liabilitiessubjecttocompromiselosscontingencylegalfees
3226055 USD
CY2014Q4 siga Liabilitiessubjecttocompromiseotheraccruedexpense
Liabilitiessubjecttocompromiseotheraccruedexpense
794750 USD
CY2015Q1 siga Liabilitiessubjecttocompromiseotheraccruedexpense
Liabilitiessubjecttocompromiseotheraccruedexpense
772874 USD
CY2015Q1 siga Number Of Active Contracts
NumberOfActiveContracts
1 contract
CY2015Q1 siga Number Of Active Grants
NumberOfActiveGrants
1 grant
CY2014Q1 siga Patent Preparation Fees
PatentPreparationFees
285736 USD
CY2015Q1 siga Patent Preparation Fees
PatentPreparationFees
333103 USD
CY2015Q1 siga Payment To Post Collateral For Surety Bond
PaymentToPostCollateralForSuretyBond
1300000 USD
CY2015Q1 siga Potential Future Aggregate Research And Development Expenses
PotentialFutureAggregateResearchAndDevelopmentExpenses
8600000 USD
CY2015Q1 siga Potentialmilestonepayments
Potentialmilestonepayments
5000000 USD
CY2015Q1 siga Potentialroyalties
Potentialroyalties
0.04
CY2014Q1 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
94675 USD
CY2015Q1 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
0 USD
CY2015Q1 siga Proof Of Claim Asserted In Connection With Litigation
ProofOfClaimAssertedInConnectionWithLitigation
194649042 USD
CY2015Q1 siga Proof Of Claim Expected To Be Withdrawn
ProofOfClaimExpectedToBeWithdrawn
971451 USD
CY2015Q1 siga Reorganization Professional Fees
ReorganizationProfessionalFees
564496 USD
CY2015Q1 siga Reorganization Trusteefees
ReorganizationTrusteefees
13000 USD
CY2014Q1 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
549415 USD
CY2015Q1 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1192092 USD
CY2015Q1 siga Researchand Development Revenue Longterm Contract
ResearchandDevelopmentRevenueLongtermContract
600000 USD
CY2015Q1 siga Suretybond
Suretybond
2700000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3384310 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3553191 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
491632 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14272317 USD
CY2014Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
17500 USD
CY2015Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
405000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2085995 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3423697 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
534775 USD
CY2015Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
544090 USD
CY2014Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
271000 USD
CY2015Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
299904 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3497251 USD
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3576029 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
175483180 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
175940813 USD
CY2014Q4 us-gaap Assets
Assets
166385335 USD
CY2015Q1 us-gaap Assets
Assets
173238862 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
129804671 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
131307728 USD
CY2015Q1 us-gaap Bankruptcy Claims Amount Of Claims Filed
BankruptcyClaimsAmountOfClaimsFiled
148 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91309754 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107067070 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99713929 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95545619 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15757316 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4168310 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53504296 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53504296 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53504296 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53504296 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
5351 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
5351 USD
CY2015Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 USD
CY2015Q1 us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
1201792 USD
CY2015Q1 us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
2537 USD
CY2014Q4 us-gaap Deferred Costs
DeferredCosts
32860874 USD
CY2015Q1 us-gaap Deferred Costs
DeferredCosts
38290122 USD
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2547479 USD
CY2015Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5016 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
81799 USD
CY2015Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
13528961 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5655928 USD
CY2015Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6251436 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5900468 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6500992 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
91106 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
78778 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
488807 USD
CY2015Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
488807 USD
CY2014Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2015Q1 us-gaap Goodwill
Goodwill
898334 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
7100000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5623154 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7069488 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2241295 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83831 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-902264 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2087773 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-371603 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13780685 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
6593554 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
5429248 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
25561191 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
13447162 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3439804 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4228642 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-19513 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10570 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-15487 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7179 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-442093 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
140829 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
253412 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2355795 USD
CY2015Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10027800 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
19044477 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
14815835 USD
CY2014Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
16688682 USD
CY2015Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
4788035 USD
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3170598 USD
CY2015Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3170598 USD
CY2014Q4 us-gaap Liabilities
Liabilities
412887812 USD
CY2015Q1 us-gaap Liabilities
Liabilities
426437025 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
166385335 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173238862 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7460253 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6976888 USD
CY2014Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
399039967 USD
CY2015Q1 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
399040346 USD
CY2014Q1 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
0 USD
CY2015Q1 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
379 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1989948 USD
CY2015Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2014Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
187820361 USD
CY2015Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
187820361 USD
CY2014Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
173000000 USD
CY2014Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
233000000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3088658 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-821264 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2000000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14184 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4000000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16592764 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6168310 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-3381859 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-7153319 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5464 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
6187850 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
6231807 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5638435 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5039715 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1262720 USD
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2174703 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1989520 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1989520 USD
CY2014Q4 us-gaap Other Liabilities
OtherLiabilities
405325 USD
CY2015Q1 us-gaap Other Liabilities
OtherLiabilities
389838 USD
CY2014Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
9706 USD
CY2015Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
10052 USD
CY2014Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2015Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
581190 USD
CY2014Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2015Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000 USD
CY2014Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
415938 USD
CY2015Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14184 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
898705 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
422521 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4329187 USD
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4329187 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
831936 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
753158 USD
CY2014Q1 us-gaap Reorganization Items
ReorganizationItems
0 USD
CY2015Q1 us-gaap Reorganization Items
ReorganizationItems
1781825 USD
CY2014Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
500001 USD
CY2015Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2813456 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2811181 USD
CY2014Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
4000000 USD
CY2015Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
0 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-421991008 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-429144327 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3087523 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
698851 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
491724 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-246502477 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
-253198163 USD
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53252155 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53504296 shares

Files In Submission

Name View Source Status
0001010086-15-000008-index-headers.html Edgar Link pending
0001010086-15-000008-index.html Edgar Link pending
0001010086-15-000008.txt Edgar Link pending
0001010086-15-000008-xbrl.zip Edgar Link pending
exhibit101-2015amendmentco.htm Edgar Link pending
exhibit102-tenthaddendumto.htm Edgar Link pending
exhibit103-01c0009amendmen.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20150331.xml Edgar Link completed
siga-20150331.xsd Edgar Link pending
siga-20150331x10q.htm Edgar Link pending
siga-20150331_cal.xml Edgar Link unprocessable
siga-20150331_def.xml Edgar Link unprocessable
siga-20150331_lab.xml Edgar Link unprocessable
siga-20150331_pre.xml Edgar Link unprocessable
siga-exhibit3112015q1.htm Edgar Link pending
siga-exhibit3122015q1.htm Edgar Link pending
siga-exhibit3212015q1.htm Edgar Link pending
siga-exhibit3222015q1.htm Edgar Link pending
tenthaddendumcorvallisleasef.jpg Edgar Link pending